Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.
Modi SS, Lehmann RP, Walters TR, Fong R, Christie WC, Roel L, Nethery D, Sager D, Tsorbatzoglou A, Philipson B, Traverso CE, Reiser H. Modi SS, et al. Among authors: lehmann rp. J Cataract Refract Surg. 2014 Feb;40(2):203-11. doi: 10.1016/j.jcrs.2013.07.042. Epub 2013 Dec 15. J Cataract Refract Surg. 2014. PMID: 24345529 Free article. Clinical Trial.
Clinical comparison of Provisc and Healon in cataract surgery.
Lehmann R, Brint S, Stewart R, White GL Jr, McCarty G, Taylor R, Disbrow D, Defaller J. Lehmann R, et al. J Cataract Refract Surg. 1995 Sep;21(5):543-7. doi: 10.1016/s0886-3350(13)80214-3. J Cataract Refract Surg. 1995. PMID: 7473117 Clinical Trial.
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Singh RP, et al. Among authors: lehmann r. Ophthalmology. 2017 Jun;124(6):776-785. doi: 10.1016/j.ophtha.2017.01.036. Epub 2017 Mar 6. Ophthalmology. 2017. PMID: 28268098 Free article. Clinical Trial.
74 results